| 
			
			 The funds will be used for expanding access to treatments for opioid 
			overdosing and to gather case data from across states, the HHS said. 
 The Centers for Disease Control and Prevention will spend $900 
			million over three years - about $301 million in the first year - to 
			help states and territories track overdose data as closely as 
			possible, the HHS said 
			https://www.hhs.gov/about/news/
 2019/09/04/trump-administration-announces-1-8-billion-funding-states-combating-opioid.html 
			in a statement.
 
			
			 
			Meanwhile, HHS unit Substance Abuse and Mental Health Services 
			Administration is awarding about $932 million to support prevention, 
			treatment and recovery services.
 Prescription opioid pain treatments and drugs like heroin and the 
			more potent fentanyl were responsible for 47,600 U.S. deaths in 
			2017, according to the government, with only a small decline last 
			year.
 
			
            [to top of second column] | 
            
			 
			Drugmakers such as Johnson & Johnson and Endo International Plc are 
			facing several lawsuits brought by states, counties and 
			municipalities that seek to hold the companies responsible for 
			opioid abuse nationwide.
 A U.S. judge on Tuesday rejected efforts by major drugmakers, 
			pharmacies and distributors to dismiss claims that they caused the 
			nation's opioid crisis, clearing the way for a landmark trial even 
			as the judge pushes for a nationwide settlement.
 
 (Reporting by Manas Mishra in Bengaluru; Editing by Shinjini Ganguli)
 
			[© 2019 Thomson Reuters. All rights 
				reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content. |